First Solana STO for Onpharma
Analysis based on 6 articles · First reported Jun 17, 2026 · Last updated Jun 17, 2026
The launch of the first Solana-based Security Token Offering (STO) for an established U.S. operating business, Onpharma, by First Block and Crito Capital LLP, is expected to modernize global private markets by enabling faster, more transparent, and lower-cost capital formation and secondary trading liquidity. This could attract more international investors to private companies and potentially increase the adoption of blockchain technology in traditional finance.
First Block, Inc., Onpharma, and Crito Capital LLP announced the launch of what is believed to be the first Solana-based Security Token Offering (STO) for an established U.S. operating business. This landmark transaction aims to modernize global private markets by deploying Solana blockchain infrastructure for issuance, settlement, and cross-border distribution of ownership rights in Onpharma's common stock. The STO is structured as a Regulation S offshore issuance for non-U.S. investors, offering improved efficiency and accessibility compared to traditional private markets. Onpharma, a dental technology firm, seeks to raise capital to expand its 'Onset EZ Pen' product, which improves local anesthetic performance.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard